Files
2026-07-06 17:27:20 -04:00

6.7 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill CONTROLLED SUBSTANCES-OPIOIDS Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately. us/states/il Illinois General Assembly 102nd HB 3596 Illinois HB 3596 (102nd)
bill
enacted
Dagmara Avelar
Emil Jones, III
4 50 2 2021-02-19 2021-08-20 openstates ocd-bill/51268020-9926-4d99-b6db-234d6ca65498 https://ilga.gov/legislation/BillStatus.asp?DocNum=3596&GAID=16&DocTypeID=HB&LegId=132636&SessionID=110&GA=102 c63dd66416db4acb3f41dea69d33a301b98657efb3324e776f7c5ff709adb1bf 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-il

Illinois HB 3596 (102nd) — CONTROLLED SUBSTANCES-OPIOIDS

Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Introduced (filed) — source
  2. Engrossed (committee substitute) — source
  3. House Amendment 001 (committee substitute) — source
  4. Enrolled (enrolled) — source

Votes

  • Third Reading — 590 (pass) · upper
  • Third Reading — 1110 (pass) · lower

Sponsors

  • Dagmara Avelar — primary (person)
  • Emil Jones, III — primary (person)
  • Aaron M. Ortiz — cosponsor (person)
  • Angelica Guerrero-Cuellar — cosponsor (person)
  • Anthony DeLuca — cosponsor (person)
  • Barbara Hernandez — cosponsor (person)
  • Christopher Belt — cosponsor (person)
  • Delia C. Ramirez — cosponsor (person)
  • Edgar Gonzalez, Jr. — cosponsor (person)
  • Elizabeth Hernandez — cosponsor (person)
  • Emanuel Chris Welch — cosponsor (person)
  • Eva-Dina Delgado — cosponsor (person)
  • Jaime M. Andrade, Jr. — cosponsor (person)
  • Joyce Mason — cosponsor (person)
  • Justin Slaughter — cosponsor (person)
  • Kathleen Willis — cosponsor (person)
  • La Shawn K. Ford — cosponsor (person)
  • Mary E. Flowers — cosponsor (person)
  • Stephanie A. Kifowit — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2021-02-19 Filed with the Clerk by Rep. Dagmara Avelar filing
  • 2021-02-22 First Reading reading-1
  • 2021-02-22 Referred to Rules Committee referral-committee
  • 2021-03-16 Assigned to Prescription Drug Affordability & Accessibility Committee referral-committee
  • 2021-03-18 Added Co-Sponsor Rep. Aaron M. Ortiz
  • 2021-03-18 Added Co-Sponsor Rep. Delia C. Ramirez
  • 2021-03-18 Added Co-Sponsor Rep. Edgar Gonzalez, Jr.
  • 2021-03-18 Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
  • 2021-03-18 Added Co-Sponsor Rep. Angelica Guerrero-Cuellar
  • 2021-03-18 Added Co-Sponsor Rep. Eva-Dina Delgado
  • 2021-03-18 Added Co-Sponsor Rep. Elizabeth Hernandez
  • 2021-03-18 Added Co-Sponsor Rep. Barbara Hernandez
  • 2021-03-25 Added Co-Sponsor Rep. Joyce Mason
  • 2021-03-25 Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 018-000-000 committee-passage
  • 2021-04-08 Placed on Calendar 2nd Reading - Short Debate
  • 2021-04-13 Second Reading - Short Debate reading-2
  • 2021-04-13 Placed on Calendar Order of 3rd Reading - Short Debate
  • 2021-04-20 House Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar amendment-introduction
  • 2021-04-20 House Floor Amendment No. 1 Referred to Rules Committee referral-committee
  • 2021-04-20 Added Co-Sponsor Rep. Emanuel Chris Welch
  • 2021-04-20 Added Co-Sponsor Rep. Stephanie A. Kifowit
  • 2021-04-20 Added Co-Sponsor Rep. Mary E. Flowers
  • 2021-04-21 House Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
  • 2021-04-21 Added Co-Sponsor Rep. Justin Slaughter
  • 2021-04-21 Added Co-Sponsor Rep. Kathleen Willis
  • 2021-04-22 House Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 017-002-000 committee-passage-favorable
  • 2021-04-22 Added Co-Sponsor Rep. Anthony DeLuca
  • 2021-04-23 Recalled to Second Reading - Short Debate reading-2
  • 2021-04-23 House Floor Amendment No. 1 Adopted amendment-passage
  • 2021-04-23 Placed on Calendar Order of 3rd Reading - Short Debate
  • 2021-04-23 Third Reading - Short Debate - Passed 111-000-000 passage, reading-3
  • 2021-04-23 Added Chief Co-Sponsor Rep. La Shawn K. Ford
  • 2021-04-27 Arrive in Senate introduction
  • 2021-04-27 Placed on Calendar Order of First Reading reading-1
  • 2021-04-27 Chief Senate Sponsor Sen. Emil Jones, III
  • 2021-04-27 First Reading reading-1
  • 2021-04-27 Referred to Assignments referral-committee
  • 2021-05-10 Assigned to Licensed Activities referral-committee
  • 2021-05-19 Do Pass Licensed Activities; 007-000-000 committee-passage
  • 2021-05-19 Placed on Calendar Order of 2nd Reading May 20, 2021
  • 2021-05-20 Added as Alternate Chief Co-Sponsor Sen. Christopher Belt
  • 2021-05-24 Second Reading reading-2
  • 2021-05-24 Placed on Calendar Order of 3rd Reading May 25, 2021
  • 2021-05-27 Placed on Calendar Order of 3rd Reading ** May 28, 2021
  • 2021-05-29 Third Reading - Passed; 059-000-000 passage, reading-3
  • 2021-05-29 Passed Both Houses
  • 2021-06-25 Sent to the Governor executive-receipt
  • 2021-08-20 Governor Approved executive-signature
  • 2021-08-20 Effective Date January 1, 2023
  • 2021-08-20 Public Act . . . . . . . . . 102-0490 became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/51268020-9926-4d99-b6db-234d6ca65498. Confidence: reported (aggregated from official Illinois legislature records).